Skip to main content

Below are some of our news stories explaining the potential dangers of Zantac, and especially the connection to NDMA contamination and stomach and bladder cancer. To learn more about the types of injuries that have been linked to this medication, and the legal claims that have been filed, click Zantac.

 
Monday, January 3, 2022

Judge Robin L. Rosenberg, who is overseeing the Zantac multidistrict litigation (MDL) in the U.S. District Court Southern District of Florida,…

Wednesday, October 6, 2021

Superior Court Judge Evelio Grillo for the County of Alameda, who oversees the California Ranitidine Product Cases Judicial Council Coordinated Proceedings (JCCP), has set a trial date of October…

Wednesday, July 22, 2020

On April 1, 2020, the Food and Drug Administration told companies to…

Thursday, April 2, 2020

On April 1, 2020, The U.S. Food and Drug Administration (FDA) announced its request that…

Tuesday, January 14, 2020

Drugmaker Mylan Pharmaceuticals, Inc. has issued a…

Sunday, January 12, 2020

Last month, Drug Safety News featured a story

Friday, September 27, 2019

With this week's revelations of NDMA contamination in the popular antacid Zantac (ranitidine), health authorities and scientists are asking just how it happened.  Frighteningly, there is evidence…

Subscribe to Zantac News